Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04175301Phase 2Active, not recruiting
A Phase 2 trial of Molecular hydrogen in malignant glioma, sponsored by Stony Brook University. Started Oct 2019; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04175301.